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Evidence of Somatic and Germinal Mosaicism in
Pseudo–Low-Penetrant Hereditary Retinoblastoma, by
Constitutional and Single-Sperm Mutation Analysis
To the Editor:
Retinoblastoma is a pediatric cancer of the retina, ini-
tiated by two consecutive inactivating mutations at the
retinoblastoma locus (RB1; Friend et al. 1986; Fung et
al. 1987; Lee et al. 1987). Tumorigenesis may occur by
two distinct pathways: in nonhereditary retinoblastoma
(60% of patients), unifocal clonal expansion occurs after
two somatic RB1 mutations in a single retinal precursor
cell; however, in hereditary retinoblastoma (40% of pa-
tients), the first RB1 mutation is inherited classically and
is present in both retinas, where uni- or multifocal tu-
morigenesis can be initiated in any cell by the somatic
mutation of the remaining allele.
Typically, germ-line mutation may be passed domi-
nantly by an affected genitor, or it can be transmitted
as a prezygotic, mostly paternal neomutation from a
healthy parent. However, postzygotic mutagenesis has
long been suspected to contribute to the pool of trans-
mittable mutations of RB1. Two main predictions char-
acterize retinoblastoma patients with mutational mo-
saicism: (1) somatic mosaicism may significantly reduce
tumor susceptibility, and (2) gonadal mosaicism may
cause linkage-based analysis of inheritance to be biased
toward apparent low penetrance, as a result of a non-
Mendelian output of mutant versus wild-type gametes.
Several cases of retinoblastoma with mosaicism are
mentioned in the literature (Greger et al. 1990; Huang
et al. 1992; Shimizu et al. 1994; Thonney et al. 1996;
Lohmann et al. 1997; Sippel et al. 1998). The incidence
of mosaicism as well as its phenotypic influence on he-
reditary retinoblastoma remain to be determined, to
improve genetic counseling and to shed light on the
mechanisms underlying expression and penetrance of
retinoblastoma.
To detect the presence of mosaicism in hereditary ret-
inoblastoma, we selected pedigrees found through either
healthy carriers or affected individuals in whom linkage
analysis concomitantly documented an apparent low
penetrance, from a series of 210 consecutive index pa-
tients referred for genetic counseling to the Retinoblas-
toma Clinics at the Jules Gonin Hospital during the pe-
riod 1986–96. Among these patients, 147 (70%) had
bilateral disease, and 34 (16.2%) had a familial history
of retinoblastoma. All patients with familial retinoblas-
toma were investigated genetically by linkage analysis
using intragenic DNA-sequence polymorphisms, and all
were informative (Munier et al. 1992, 1996). Apparent
low penetrance was present in eight pedigrees. After the
exclusion of two families with fortuitous familial ag-
gregation of independent retinoblastoma cases (Munier
et al. 1993), the six remaining pedigrees were docu-
mented for reduced penetrance, as defined by the pres-
ence of healthy individuals 13 years of age in linkage
phase with affected family members. A systematic search
for the RB1 mutation in these six families was then per-
formed in order to describe the molecular basis of the
presumed low penetrance.
Among the six families (A–F) with apparent low pen-
etrance, linkage analysis detected 21 unaffected carriers,
of whom 6 were obligate retinoblastoma transmitters;
2 of the 6 obligate transmitters were founders (in families
A and B; data not shown). The other four pedigrees were
founded either by unilaterally (families C, D, and F) or
bilaterally (family E) affected males, and attenuated ex-
pressivity or retinoma was present in three of these
males: two in family E (the affected father had one eye
enucleated for unilateral retinoblastoma and a unifocal
flat chorioretinal scar, reminiscent of type IV regression,
in his untreated eye; the affected son had bilateral mul-
tifocal retinomas) and one in family F (the affected
grandfather had a unifocal staphylomic macular scar).
Two abnormal conformers were identified when SSCP
analysis of exons 8 and 23 was performed for the two
index patients of families D and E, respectively (fig. 1).
Sequence analysis of these DNA fragments revealedCrT
transitions at CpG dinucleotides of two arginine codons,
at positions 251 and 787, in families D and E, respec-
tively. These changes also abolished two TaqI restriction
sites. When segregation of the mutations was analyzed
in both families, the TaqI restriction digest showed a
faint undigested band in affected fathers, in addition to
the expected digested products, suggesting the presence
of somatic mosaicism. Confirmation of mosaicism was
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Figure 1 Pedigrees of two low-penetrant retinoblastoma families (D and E), and genotypes after linkage and/or mutation analysis at the
RB1 locus. mw  heterozygote for the RB1 mutation, ww  homozygote for the RB1 wild type, w/(m/w)  mosaic, and lis  esterase D
lisbon isoenzyme. The blackened circle represents a bilaterally affected female patient; half-blackened squares represent unilaterally affected
males; hatched and half-hatched squares represent patients with bilateral and unilateral retinomas, respectively; and squares containing a black
dot represent unaffected male carriers of the apparently disease-linked haplotype.
obtained following analysis of the TaqI site in cloned
PCR amplicons of exons 8 and 23. The mutant digestion
pattern was recovered in only 8 (10.7%) of 75 inserts
from family D and in 4 (12.1%) of 33 inserts from family
E. In contrast with the results of the linkage analysis,
nonpenetrance failed to be validated by the presence of
mutations in the three unaffected sibs (individuals III-1
and III-2 in family D and individual III-2 in family E)
of the probands, strongly suggesting germinalmosaicism
in the founders.
Direct quantitative analysis of gonadal mosaicismwas
performed on semen from only the family E founder (fig.
2), by means of a TaqI restriction assay in amplicons of
exon 23. Single sperms were isolated by fluorescence-
activated cell sorting into 96-well microtiter plates (Cui
et al. 1989; Li et al. 1991). We performed amplification
reactions in 576 wells and obtained an amplification
signal for 415 wells. No amplification was obtained for
the 40 negative controls (wells without cells), which is
consistent with absence of contamination. All 18 posi-
tive controls (10 spermatozoa/well) gave a signal on an
agarose gel; two alleles were observed in 3 wells, indi-
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Figure 2 Determination of genotypes in single sperm from pa-
tient II-1 from family E, as detected by ethidium-bromide staining of
TaqI-digested PCR products. Lane 1, Undigested PCR product. Lane
2, Digested PCR product from 10 spermatozoa (presence of the two
alleles). Lanes 3–6, PCR product from single sperm with a mutant
allele (lane 4) or a normal allele (lanes 3, 5, and 6). LaneM,Molecular-
weight marker (1-kb ladder; Gibco BRL).
cating the presence of more than one spermatocyte. The
remaining 394 wells had only one allele. The mutated
and wild-type alleles were easily distinguished, afterTaqI
digestion, as one 255-bp amplicon or as products of
bp, respectively (fig. 2). Of 394 unicellular159 96
digested products, 365 (92.64%) revealed the presence
of a normal allele, and 29 (7.36%) revealed the presence
of a mutant allele.
Intragenic linkage analysis of 34 familial retinoblas-
toma cases revealed a low-penetrance pattern of in-
heritance in eight families, of which four followed
pseudo–low-penetrant mechanisms, including indepen-
dent occurrence of RB1 mutations in two different sets
of cousins (Munier et al. 1993) and, as shown in this
study, germ-line mosaicism in two affected founders. For
the four remaining families, the molecular basis of the
apparent low penetrance could not be determined and
will await identification of the disease-causing muta-
tion(s). Given the reported sensitivity (26%–83%) of the
various RB1 mutation-scanning methods for hereditary
retinoblastoma (Blanquet et al. 1995; Liu et al. 1995;
Lohmann et al. 1996), the observation of mutations in
33% of the cases was not surprising. One possible ex-
planation is that several mutations can be missed by
SSCP screening or may lie outside the scanned RB1 ex-
ons (exons 2–26). Analysis of incomplete penetrance in
retinoblastoma has previously led to the identification
of two major types of gene alterations, resulting in either
transcription reduction via a promoter mutation (Sakai
et al. 1991; Cowell et al. 1996) or partial protein in-
activation via missense mutations (Kratzke et al. 1994;
Lohmann et al. 1994; Ahmad et al. 1997) and in-frame
deletions (Lohmann et al. 1992; Dryja et al. 1993; Brem-
ner et al. 1997; Schubert et al. 1997).
We report two affected patients with somatic and
gonadal mosaicism for two RB1 nonsense mutations
(R251X and R787X). The pathogenicity of these two
mutations has been well established (Yandell et al. 1989;
Cowell et al. 1994). For both affected patients, somatic
mosaicism has been documented in peripheral lympho-
cytes and possibly involves the retina, as suggested by
the nonpenetrance of retinoblastoma in one eye of the
founder of family D. Mosaicism further extends to in-
clude the germ line, as proved by the segregation of three
different chromosomes 13 in both families (fig. 1). In
family D, indirect evidence of gonadal mosaicism in the
father was provided by the analysis of three informative
meiotic events in his progeny, after exclusion of non-
paternity, since his affected girl and two unaffected sons
inherited the same paternal haplotype, including a rare
esterase D polymorphism, ESD*Lis (Munier et al. 1988).
In family E, direct evidence of germ-line mosaicism in
the father’s semen is based on the study of 394 meiotic
events, fromwhich 7.3% of the spermatozoa aremutant,
which is not very different from the 12.1% observed in
the peripheral leukocyte DNA.
In contrast to the ectodermal lineage of the retina,
leukocytes and primordial germ cells have an extraem-
bryonic origin and derive from the blastocyst endoderm.
Since the didermic stage starts at ∼8 d after conception,
it is tempting to adopt this age as the upper limit for
the occurrence of the postzygotic mutations R251X and
R787X. On the other hand, the earliest mutational event
leading to mosaicism can already have taken place in
the postmeiotic gametes, as “half-chromatid mutations”
(Carlson and Desnick 1979). The fact that the mutations
in both mosaics occurred on the paternally derived chro-
mosomes suggests that the well-known preferential pre-
zygotic paternal mutagenesis (Dryja et al. 1989; Zhu et
al. 1989) lasted in the zygote until the 8th d of devel-
opment. Interestingly, these two mutations are CrT
transitions at CpG dinucleotides, most likely occurring
by spontaneous 5-methylcytosine deamination. In sup-
port of this mutational mechanism, the genome of hap-
loid spermatozoa is known to have a higher methylation
content than the undermethylated DNA of the oocyte
and to be completely devoid of repair capabilities (Monk
1995). Hypermutability of the male-derived conceptus
genome may be momentarily repressed following the
massive demethylation that takes place at ∼2 d after
conception. De novo methylation of the unmethylated
blastocyst genome occurs again, at ∼6 d after concep-
tion, at the time of implantation (Dost and Lee 1995;
Razin and Shemer 1995). The CpG of codon 251 in
RB1 was recently proved to be constitutivelymethylated,
whereas no information is yet available with regard to
the methylation status of the CpG of codon 787 (Man-
cini et al. 1997). In summary, we tentatively can assign
a mutational window spanning from shortly before fer-
tilization to the 8th d of development. Since both ob-
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served mutations in the two mosaics occurred on the
paternally derived chromosomes, most likely following
a cytosine methylation–mediated mechanism, the mu-
tational events involved likely happened no later than 2
d after conception, on the methylated paternal genome,
before massive demethylation took place. Furthermore,
we postulate that the different methylation status be-
tween sperm and oocyte genomes may temporarily per-
sist in the zygote and, hence, may cause a preferential
paternal origin of mosaicism.
This study indicates that hereditary retinoblastoma
does not originate exclusively from gametic neomuta-
tions but also may result from embryonic mutagenesis.
The relative contribution of gametic and embryonic neo-
mutations in hereditary retinoblastoma remains un-
known but may be determined by systematic screening
for both somatic mosaicism in patients with presumed
de novo mutations and cryptic mosaicism in their par-
ents. The time interval between the end of meiosis and
the differentiation of soma from the germ line is viewed
by some as a significant source of transmittable domi-
nant neomutations, with estimates ranging from 5% to
115% (Dost and Lee 1995).
The mosaic nature of the two mutations described in
this study could not be detected in any of the other 10
germ-line mutations identified by us (data not shown).
A search was performed in index patients and their
healthy parents. On the basis of this small series, we
estimated a mosaic prevalence of 16.6% (2/12). Inter-
estingly, Lohmann et al. (1997) estimated a similar prev-
alence, with 1 (16.6%) in 6 mutations that cause isolated
unilateral hereditary retinoblastoma found to be mosaic
in nature. Such a frequent occurrence of mosaicism was
also highlighted recently by Sippel et al. (1998), whose
data indicate a 10% rate of mosaicism in a population
of 156 retinoblastoma patients. Finally, in a review of
140 retinoblastoma cases associated with constitutional
13q14 chromosomal rearrangements, 25 (18%) had
proved mosaicism (Munier et al. 1989).
Taken together, these data suggest that mosaicismmay
be a frequent phenomenon, often interfering with ex-
pression and transmission of retinoblastoma. Somatic
mosaicism may cause attenuated expression, such as uni-
laterality or nonpenetrance of retinoblastoma. Likewise,
germinal mosaicism may be associated with apparent
reduced penetrance of retinoblastoma in linkage-based
molecular assessments of inheritance. This fact should
be included in the calculation of the recurrence risk of
retinoblastoma, especially for families with unilaterally
affected male founders.
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